<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03872011</url>
  </required_header>
  <id_info>
    <org_study_id>2019KY-145</org_study_id>
    <nct_id>NCT03872011</nct_id>
  </id_info>
  <brief_title>Vitamin C, Thiamine and Hydrocortisone for the Treatment of Septic Shock</brief_title>
  <official_title>Initiation of Vitamin C, Thiamine and Hydrocortisone Therapy for Septic Shock in Adults: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northern Jiangsu Province People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northern Jiangsu Province People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the combination therapy (vitamin C,thiamine&#xD;
      and hydrocortisone) is effective in the treatment of septic shock.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Septic Shock is a leading cause of morbidity and mortality in critically ill patients&#xD;
      worldwide.&#xD;
&#xD;
      A potential benefit of vitamin C with thiamine and low-dose hydrocortisone in the treatment&#xD;
      of septic shock has recently been described(PMID 27940189) . The patients with septic shock&#xD;
      who received this combination of medications weaned off pressors earlier, suffered less organ&#xD;
      failure, and had improved mortality. The doses of vitamin C used in this trial are high, yet&#xD;
      seemed to be safe and can be considered for use.&#xD;
&#xD;
      In this randomized controlled trial, we aim to evaluate the effect of the combination therapy&#xD;
      (vitamin C,thiamine and hydrocortisone) on septic shock.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 19, 2019</start_date>
  <completion_date type="Actual">September 20, 2021</completion_date>
  <primary_completion_date type="Actual">September 20, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>90-day mortality</measure>
    <time_frame>90 days after randomization</time_frame>
    <description>Death from any cause at 90 days after the onset of septic shock</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>90 days after randomization</time_frame>
    <description>All-cause mortality at ICU discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>90 days after randomization</time_frame>
    <description>All-cause mortality at hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>28 days after randomization</time_frame>
    <description>Death from any cause at 28 days after the onset of septic shock</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">408</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Vitamin C,thiamine,hydrocortisone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The combination of vitamin C, thiamine, hydrocortisone :&#xD;
Vitamin C 2g every 6 hours x 5-days Thiamine 200mg every 12 hours x 5-days Hydrocortisone 200mg as a continuous infusion x 5-days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal Saline Solution (0.9%NaCl) in a volume to match all experimental arm components</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin C,thiamine,hydrocortisone</intervention_name>
    <description>Vitamin C (2g) will be diluted in 100ml 0.9%NACL and administered ivd every 6 hours for 5 days or until participant is discharged from the ICU.&#xD;
Thiamine(200mg) will be diluted in 100ml 0.9%NACL and administered ivd every 12 hours for 5 days or until participant is discharged from the ICU. Hydrocortisone was administered 200 mg/d as a continuous infusion for 5 days or until participant is discharged from the ICU.</description>
    <arm_group_label>Vitamin C,thiamine,hydrocortisone</arm_group_label>
    <other_name>Ascorbic Acid</other_name>
    <other_name>Vitamin B1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Normal saline (0.9% NaCl solution) volume to match all components</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 years old or older&#xD;
&#xD;
          -  Onset of septic shock within 12 hours&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Systemic corticosteroid therapy within the last 3 months before septic shock&#xD;
&#xD;
          -  High-dose steroid therapy&#xD;
&#xD;
          -  Immunosuppression&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Known glucose-6 phosphate dehydrogenase (G-6PD) deficiency&#xD;
&#xD;
          -  Known hemachromatosis&#xD;
&#xD;
          -  Known allergy to vitamin C, hydrocortisone, or thiamine&#xD;
&#xD;
          -  Anticipated death from a preexisting disease within 90 days after randomization (as&#xD;
             determined by the enrolling physician)&#xD;
&#xD;
          -  Refusal of the attending staff or patient family&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qingquan Lyu, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northern Jiangsu Province People's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northern Jiangsu Province people's hospital</name>
      <address>
        <city>Yangzhou</city>
        <state>Jiangsu</state>
        <zip>225000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 4, 2019</study_first_submitted>
  <study_first_submitted_qc>March 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2019</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northern Jiangsu Province People's Hospital</investigator_affiliation>
    <investigator_full_name>Qing-quan Lv</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>septic shock</keyword>
  <keyword>vitamin C</keyword>
  <keyword>thiamine</keyword>
  <keyword>hydrocortisone</keyword>
  <keyword>mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Thiamine</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

